Surging demand for GLP-1 drugs has outstripped production capacity, leading to shortages and supply delays
2 Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey Correspondence: Nimet Ylmaz, Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey, Email [email protected] Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists are highly effective agents for the treatment of type 2 diabetes and obesity
The impact is real, with transaction-based research showing that households using GLP-1 therapy reduced spending at fast-food, coffee, and other limited-service outlets by roughly 8% in the first six months after starting their prescription 6
These protein bites are made for that moment